OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Low-doses aspirin in the primary prevention of cardiovascular disease in patients with diabetes: Meta-analysis stratified by baseline cardiovascular risk
Walter Masson, Leandro Barbagelata, Augusto Lavalle Cobo, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2022) Vol. 16, Iss. 1, pp. 102391-102391
Closed Access | Times Cited: 12
Walter Masson, Leandro Barbagelata, Augusto Lavalle Cobo, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2022) Vol. 16, Iss. 1, pp. 102391-102391
Closed Access | Times Cited: 12
Showing 12 citing articles:
Ten things to know about ten cardiovascular disease risk factors – 2022
Harold Bays, Anandita Agarwala, Charles German, et al.
American Journal of Preventive Cardiology (2022) Vol. 10, pp. 100342-100342
Open Access | Times Cited: 82
Harold Bays, Anandita Agarwala, Charles German, et al.
American Journal of Preventive Cardiology (2022) Vol. 10, pp. 100342-100342
Open Access | Times Cited: 82
2023 Clinical Practice Guidelines for Diabetes Management in Korea: Full Version Recommendation of the Korean Diabetes Association
Jun Sung Moon, Shinae Kang, Jong Han Choi, et al.
Diabetes & Metabolism Journal (2024) Vol. 48, Iss. 4, pp. 546-708
Open Access | Times Cited: 11
Jun Sung Moon, Shinae Kang, Jong Han Choi, et al.
Diabetes & Metabolism Journal (2024) Vol. 48, Iss. 4, pp. 546-708
Open Access | Times Cited: 11
Factors Associated with Platelet Activation-Recent Pharmaceutical Approaches
Panagiotis Theofilis, Μarios Sagris, Evangelos Oikonomou, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3301-3301
Open Access | Times Cited: 27
Panagiotis Theofilis, Μarios Sagris, Evangelos Oikonomou, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3301-3301
Open Access | Times Cited: 27
Levels of adherence to treatment, illness perception and acceptance of illness in patients with coronary artery disease - descriptive and correlational study
Farzad Dugunchi, Shiv Kumar Mudgal, Zohreh Hosseini Marznaki, et al.
BMC Cardiovascular Disorders (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Farzad Dugunchi, Shiv Kumar Mudgal, Zohreh Hosseini Marznaki, et al.
BMC Cardiovascular Disorders (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
The interplay of factors in metabolic syndrome: understanding its roots and complexity
Md. Sharifull Islam, Ping Wei, Md Suzauddula, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 4
Md. Sharifull Islam, Ping Wei, Md Suzauddula, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 4
ASSESSING THE IMPACT OF LOW-DOSE ASPIRIN ON CARDIOVASCULAR DISEASE PREVENTION IN DIABETIC PATIENTS
Heena Jilani, Naheed Shah, Anurag Rawat, et al.
(2025) Vol. 3, Iss. 3 (Health & Allied), pp. 60-64
Closed Access
Heena Jilani, Naheed Shah, Anurag Rawat, et al.
(2025) Vol. 3, Iss. 3 (Health & Allied), pp. 60-64
Closed Access
Molecular Biological and Clinical Understanding of the Statin Residual Cardiovascular Disease Risk and Peroxisome Proliferator-Activated Receptor Alpha Agonists and Ezetimibe for Its Treatment
Hidekatsu Yanai, Hiroki Adachi, Mariko Hakoshima, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3418-3418
Open Access | Times Cited: 15
Hidekatsu Yanai, Hiroki Adachi, Mariko Hakoshima, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3418-3418
Open Access | Times Cited: 15
Benefits and Risks Associated with Low-Dose Aspirin Use for the Primary Prevention of Cardiovascular Disease: A Systematic Review and Meta-Analysis of Randomized Control Trials and Trial Sequential Analysis
Mingming Wang, Haijie Yu, Zuojing Li, et al.
American Journal of Cardiovascular Drugs (2022) Vol. 22, Iss. 6, pp. 657-675
Closed Access | Times Cited: 15
Mingming Wang, Haijie Yu, Zuojing Li, et al.
American Journal of Cardiovascular Drugs (2022) Vol. 22, Iss. 6, pp. 657-675
Closed Access | Times Cited: 15
Aspirin for Primary Prevention of Cardiovascular Diseases: “WALTZ” with the Evidence
Kyriakos Dimitriadis, Emilia Lazarou, Panagiotis Tsioufis, et al.
Current Cardiology Reports (2022) Vol. 24, Iss. 9, pp. 1139-1147
Open Access | Times Cited: 5
Kyriakos Dimitriadis, Emilia Lazarou, Panagiotis Tsioufis, et al.
Current Cardiology Reports (2022) Vol. 24, Iss. 9, pp. 1139-1147
Open Access | Times Cited: 5
Aspirin use in patients with elevated Lipoprotein(a): Impact on cardiovascular events and bleeding.
Walter Masson, Leandro Barbagelata, Juan Patricio Nogueira
Current Problems in Cardiology (2024) Vol. 49, Iss. 11, pp. 102827-102827
Closed Access
Walter Masson, Leandro Barbagelata, Juan Patricio Nogueira
Current Problems in Cardiology (2024) Vol. 49, Iss. 11, pp. 102827-102827
Closed Access
Low‐dose aspirin for prevention of cardiovascular mortality in patients with type 2 diabetes and chronic kidney disease: A real‐world nationwide cohort study
Yi Lin, Bi‐Li Chen, Wan‐Ting Chen, et al.
Journal of Diabetes Investigation (2023) Vol. 15, Iss. 4, pp. 459-467
Open Access | Times Cited: 1
Yi Lin, Bi‐Li Chen, Wan‐Ting Chen, et al.
Journal of Diabetes Investigation (2023) Vol. 15, Iss. 4, pp. 459-467
Open Access | Times Cited: 1
2023 Clinical Practice Guidelines for Diabetes: Management of Cardiovascular Risk Factors
Ye Yang
Journal of Korean Diabetes (2023) Vol. 24, Iss. 3, pp. 135-140
Open Access
Ye Yang
Journal of Korean Diabetes (2023) Vol. 24, Iss. 3, pp. 135-140
Open Access
